Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Montel Williams joins Cannformatics' Advisory Board

Cannformatics announced that Emmy Award-winning television personality, medical cannabis advocate, and entrepreneur Montel Williams has joined its Advisory Board. Mr. Williams will serve as a Media and Cannabis Industry Advisor to the company as it works to complete the final phase of research prior to launching its first commercial service for patients with an autism spectrum disorder.


Montel Williams 

"Cannformatics' mission is to provide patients, with any medical condition treatable by cannabis, with the medical information they and their physicians need to improve health and quality of life. Montel, as both a medical cannabis patient and advocate, has been on this mission for over twenty years. We are honored to have him join our Advisory Board," said Cannformatics CEO and Cofounder Dr. Itzhak Kurek. "Montel is joining the Board at a perfect time as we prepare for the launch of our first commercial platform. We look forward to his advice and counsel as we ramp up outreach to patients, physicians, and the medical cannabis industry."

Montel Williams is an advocate for medical cannabis in the country. He has used medical cannabis products to effectively manage the symptoms of his Multiple Sclerosis (MS) since his diagnosis with the disease in 1999. Williams is also the founder of Lenitiv Scientific LLC, a cannabis product and branding company. In 2020 Williams launched his debut podcast, Let's Be Blunt with Montel. It was on that program where Williams met Dr. Kurek, who was a guest on his show.

"For decades, politicians, regulators, and much of the medical community have not just ignored medical cannabis, they have contributed to the stigma patients face today. The science and data Cannformatics are developing cannot be ignored or dismissed. This company is quantifying the impact of cannabis on real patients, and I can't wait to help them tell their story," said Williams.

For more information:
Cannformatics 
www.cannformatics.com 

Publication date: